• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Bayer HealthCare AG Market Share Analysis - Product Image

Bayer HealthCare AG Market Share Analysis

  • Published: October 2012
  • Region: Global
  • 119 pages
  • GlobalData

FEATURED COMPANIES

  • Abbott Laboratories
  • Arkray, Inc.
  • BIONIME Corporation
  • GlaxoSmithKline plc
  • LifeScan, Inc.
  • Merck & Co., Inc.
  • MORE

Bayer HealthCare AG Market Share Analysis

Summary

Our new report, “Bayer HealthCare AG Market Share Analysis” provides in-depth information on Bayer HealthCare AG’s market position in the different medical equipment markets it operates in. The report provides Bayer HealthCare AG market share information in one key market category – Glucose monitoring devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Global company shares (in Revenues) information for the key markets Bayer HealthCare AG operates in – Diabetes Care Devices.
- Bayer HealthCare AG’s company shares (in Revenues) information for all the key countries the company READ MORE >

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets/Categories Covered
3.1 Diabetes Care Devices
3.1.1 Glucose Monitoring
4 Company Snapshot
4.1 Key Information
4.2 Company Overview
4.3 SWOT Snapshot
5 Business Description
5.1 Business Overview
5.2 Animal Health
5.2.1 Overview
5.2.2 Financials
5.3 Consumer Care
5.3.1 Overview
5.3.2 Financials
5.4 Medical Care
5.4.1 Overview
5.4.2 Financials
5.4.3 Market View
5.5 Pharmaceuticals
5.5.1 Overview
5.5.2 Financials
5.5.3 Market View
5.6 Major Products and Services
5.6.1 Overview
6 History
7 Business Strategy
7.1 Mission Statement
8 SWOT Analysis
8.1 Overview
8.2 Bayer HealthCare AG Strengths
8.2.1 Focused Research and Development Activities
8.2.2 Broad Product Offerings
8.2.3 Strong Market Position
8.2.4 Geographical Diversity
8.3 Bayer HealthCare AG Weaknesses
8.3.1 Legal Proceedings
8.4 Bayer HealthCare AG Opportunities
8.4.1 Regulatory Approvals
8.4.2 Global Diagnostic Imaging Market
8.4.3 Market Growth in Emerging Economies
8.4.4 Growing Diabetes Care Devices Market
8.5 Bayer HealthCare AG Threats
8.5.1 Changing Diagnostic Market Conditions
8.5.2 Growing Parallel Trade
8.5.3 Uncertain R&D Outcomes
8.5.4 Stringent Government Regulations
9 Competitors
10 Competitive Landscape
10.1 Diabetes Care Devices (Glucose Monitoring), Global, Market Share (%), 2011
10.2 Bayer HealthCare AG, Diabetes Care Devices(Glucose Monitoring), by Region, Market Share (2011)
10.3 Bayer HealthCare AG, Diabetes Care Devices(Glucose Monitoring), by Country, Market Share (2011)
11 Key Employees
12 Key Employee Biographies
13 Company Statement
14 Locations And Subsidiaries
14.1 Head Office
14.2 Other Locations & Subsidiaries
15 Financial Deals Landscape
15.1 Bayer HealthCare AG, Deals Volume Summary, 2006 to YTD 2012
16 Bayer HealthCare AG Detailed Deal Summary
16.1 Partnerships
16.1.1 Bayer HealthCare Enters Into Co-Marketing Agreement With Radimetrics For eXposure
16.1.2 Bayer HealthCare Diabetes Care Expands Partnership With Medtronic
16.1.3 Bayer HealthCare Enters Into Joint Venture Agreement With Zydus Cadila Healthcare
16.1.4 Bayer HealthCare Enters Into Joint Venture Agreement With Tsinghua University
16.1.5 Bayer HealthCare Diabetes Care Signs An Agreement With Medtronic
16.1.6 Activaero Enters Into Licensing Agreement With Bayer HealthCare
16.2 Asset Transactions
16.2.1 Siemens Healthcare Diagnostics Completes Acquisition Of Manufacturing Plant In Mishawaka From Bayer HealthCare
16.2.2 Siemens Medical Solutions Acquires Diagnostics Division Of Bayer Healthcare
16.3 Acquisition
16.3.1 Bayer HealthCare Completes Acquisition Of iSense
16.3.2 Bayer HealthCare Diabetes Care Acquires Metrika
17 Recent Developments
17.1 Strategy And Business Planning
17.1.1 Jan 19, 2012: Bayer HealthCare Expands Research And Manufacturing Capabilities For Interventional Franchise
17.1.2 Apr 04, 2011: Bayer HealthCare Selects State Of New Jersey For East Coast Site Consolidation
17.1.3 Mar 04, 2011: Bayer Extends Agreement With WHO To Fight Chagas Disease
17.1.4 Jan 31, 2011: Bayer HealthCare Announces Organizational Changes
17.1.5 Jun 02, 2009: Bayer, Genzyme Finalize Strategic Alliance
17.2 Financial Announcements
17.2.1 Oct 27, 2009: Bayer Posts Group Net Income Of EUR249 Million For Q3 2009
17.2.2 Jul 29, 2009: Bayer Posts Group Net Income Of EUR532 Million For Q2 2009
17.2.3 Apr 29, 2009: Bayer Posts Group Net Income Of EUR425 Million For Q1 2009
17.2.4 Mar 03, 2009: Bayer Declares 2008 Results with Increase In Revenue Of 1.6%
17.2.5 Oct 29, 2008: Bayer HealthCare Reports 3Q 2008 Results
17.2.6 Jul 30, 2008: Bayer Reports 2Q 2008 Results
17.2.7 Apr 24, 2008: Bayer Reports 1Q 2008 Results
17.2.8 Feb 28, 2008: Bayer Reports 4Q 2007 Results
17.2.9 Nov 06, 2007: Bayer Declares Q3 2007 Results
17.2.10 Aug 07, 2007: Bayer Declares Q2 2007 Results
17.2.11 Apr 26, 2007: Bayer Declares Q1 2007 Results
17.2.12 Mar 15, 2007: Bayer Declares 2006 Results
17.3 Research And Development
17.3.1 Jan 09, 2012: Bayer HealthCare To Share Lab Space With Start-Up Companies
17.3.2 Dec 13, 2010: Bayer Builds New Facility Worth EUR35 Million For Biological Development
17.3.3 May 28, 2009: Bayer HealthCare To Initiate Phase III Trial For Liver Cancer Drug
17.4 Corporate Communications
17.4.1 Apr 22, 2010: Bayer HealthCare Appoints Dr. Jorg Reinhardt As New CEO
17.4.2 Apr 21, 2010: Bayer HealthCare Names Jorg Reinhardt As CEO
17.4.3 Aug 05, 2008: Bayer Appoints President, CEO To Its BBTS
17.4.4 Jul 31, 2008: Bayer Names New US CEO
17.4.5 Sep 05, 2007: Bayer Intends To Delist From NYSE
17.5 Government and Public Interest
17.5.1 Mar 28, 2012: Bayer To Present New Data On Oncology Pipeline
17.5.2 Aug 15, 2011: Bayer To Support WHO And Stop Tuberculosis Partnership In Fighting Tuberculosis
17.5.3 Aug 07, 2009: FDA Approves New 3000 IU Vial Size For Kogenate FS
17.6 Product News
17.6.1 Sep 04, 2012: Bayer’s New Contour Next Link Blood Glucose Meter Now Available With Compatible Medtronic Insulin Pumps
17.6.2 Aug 23, 2012: Bayer Initiates Global Clinical Phase III Programme RESPIRE For Ciprofloxacin DPI
17.6.3 Jun 20, 2012: Bayer Launches Medrad Mark 7 Arterion Injection System
17.6.4 Jun 11, 2012: Clinical Study Shows Bayer's New CONTOUR Next EZ Blood Glucose Monitoring System Easy To Use With High Level Of Accuracy
17.6.5 Apr 18, 2012: Bayer HealthCare Receives FDA Clearance For Its CONTOUR Next EZ BGM System
17.6.6 Dec 14, 2011: Bayer HealthCare Submits New Intrauterine System For Marketing Authorization In EU And In US
17.6.7 Dec 05, 2011: Bayer Starts First Outcome Study With Contour USB
17.6.8 Oct 10, 2011: Bayer’s Contour Delivers Reliable Readings For Diabetes Self-Management: Study
17.6.9 Jun 09, 2010: Bayer's CONTOUR USB Blood Glucose Meter Wins Medical Design Excellence Award
17.6.10 Apr 26, 2010: Bayer Introduces DIDGET Blood Glucose Monitoring System In US
17.6.11 Mar 24, 2010: Bayer Announces Health Canada Approval For CONTOUR USB Blood Glucose Meter
17.6.12 Mar 01, 2010: Bayer Launches CONTOUR USB Blood Glucose Meter In UK And Ireland
17.6.13 Feb 16, 2010: Bayer Diabetes Care Launches A1CNow SELFCHECK
17.6.14 Jan 04, 2010: Bayer To Complete Its On-Going Phase III Trial For FC Patch In Second Half Of 2010
17.6.15 Jan 04, 2010: Bayer To Complete Phase II German Study For FC Patch In Third Quarter Of 2010
17.6.16 Nov 17, 2009: Bayer Announces Online Commercialization Of CONTOUR USB Meter
17.6.17 Oct 01, 2009: Bayer HealthCare Announces FDA Approval Of Mirena For Heavy Menstrual Bleeding In Women
17.6.18 Sep 28, 2009: Bayer Launches DIDGET Blood Glucose Meter For Children
17.6.19 Sep 21, 2009: Bayer Receives FDA Approval For CONTOUR USB Blood Glucose Meter With Unique Plug And Play Diabetes Management Software
17.6.20 Jul 13, 2009: Bayer Showcases DIDGET
17.6.21 Jun 02, 2009: Bayer Diabetes Care Announces The Launch Of A1CNow SELFCHECK
17.6.22 May 05, 2009: Bayer HealthCare Releases CONTOUR Meters In Two Bold New Colors, The Midnight Blue And Orange Burst
17.6.23 Sep 24, 2008: Bayer HealthCare Pharmaceuticals Launching New Needle For Betaseron
17.6.24 Sep 08, 2008: Bayer Featured Redesigned MICROLET 2 Lancing System At European Association
17.6.25 Mar 11, 2008: Bayer HealthCare Pharmaceuticals Introduces VistaTrak An Innovative Contrast Media Management System
17.6.26 Dec 01, 2007: Bayer To Preview VistaTrak At RSNA 2007
17.6.27 May 04, 2007: Bayer Develops Wound Dressings On The Basis Of Silica Gel Fiber
17.7 Product Approvals
17.7.1 Apr 18, 2012: Bayer HealthCare Receives FDA Clearance For Its CONTOUR Next EZ BGM System
17.7.2 Mar 24, 2010: Bayer Announces Health Canada Approval For CONTOUR USB Blood Glucose Meter
17.7.3 Oct 01, 2009: Bayer HealthCare Announces FDA Approval Of Mirena For Heavy Menstrual Bleeding In Women
17.7.4 Sep 21, 2009: Bayer Receives FDA Approval For CONTOUR USB Blood Glucose Meter With Unique Plug And Play Diabetes Management Software
17.8 Clinical Trials
17.8.1 Aug 23, 2012: Bayer Initiates Global Clinical Phase III Programme RESPIRE For Ciprofloxacin DPI
17.8.2 Jun 11, 2012: Clinical Study Shows Bayer's New CONTOUR Next EZ Blood Glucose Monitoring System Easy To Use With High Level Of Accuracy
17.8.3 Dec 05, 2011: Bayer Starts First Outcome Study With Contour USB
17.8.4 Oct 10, 2011: Bayer’s Contour Delivers Reliable Readings For Diabetes Self-Management: Study
17.8.5 Jan 04, 2010: Bayer To Complete Phase II German Study For FC Patch In Third Quarter Of 2010
17.8.6 Jan 04, 2010: Bayer To Complete Its On-Going Phase III Trial For FC Patch In Second Half Of 2010
17.9 Other Significant Developments
17.9.1 Sep 26, 2012: Bayer Joins Global Initiative For Better Access To Safe And Effective Contraception
17.9.2 Jul 10, 2012: Bayer Announces 2012 Recipients Of Bayer Hemophilia Awards Program
17.9.3 Jan 04, 2012: Intendis Changes Name To Bayer HealthCare
17.9.4 Jul 12, 2010: Bayer HealthCare Provides $2.5 Million Funding To Advance Global Hemophilia Research And Patient Care
17.9.5 Jan 15, 2010: Bayer Donates Medicines Worth EUR90,000 To Victims Of Earthquake In Haiti
18 Appendix
18.1 Research Methodology
18.2 Secondary Research
18.3 Primary Research
18.4 Models
18.5 Forecasts
18.6 Expert Panels
18.7 Consulting
18.8 Currency Conversion
18.9 Contact Us
18.10 Disclaimer

1.1 List of Tables
Table 1: Bayer HealthCare AG, Key Facts, 2011
Table 2: Bayer HealthCare AG, SWOT Analysis, 2011
Table 3: Diabetes Care Devices (Glucose Monitoring), Global, Company Share by Revenue ($m), 2011
Table 4: Bayer HealthCare AG, Diabetes Care Devices (Glucose Monitoring), by Region, Revenue ($m) and Market Share (%), 2011
Table 5: Bayer HealthCare AG, Diabetes Care Devices (Glucose Monitoring), by Country, Revenue ($m) and Market Share (%), 2011
Table 6: Bayer HealthCare AG, Key Employees
Table 7: Bayer HealthCare AG, Other Locations
Table 8: Bayer HealthCare AG, Subsidiaries
Table 9: Bayer HealthCare AG, Deals Volume Summary, 2006 to YTD 2012
Table 10: Bayer HealthCare AG, Deals Summary, 2006 to YTD 2012
Table 11: Bayer HealthCare Enters Into Co-Marketing Agreement With Radimetrics For eXposure
Table 12: Bayer HealthCare Diabetes Care Expands Partnership With Medtronic
Table 13: Bayer HealthCare Enters Into Joint Venture Agreement With Zydus Cadila Healthcare
Table 14: Bayer HealthCare Enters Into Joint Venture Agreement With Tsinghua University
Table 15: Bayer HealthCare Diabetes Care Signs An Agreement With Medtronic
Table 16: Activaero Enters Into Licensing Agreement With Bayer HealthCare
Table 17: Siemens Healthcare Diagnostics Completes Acquisition Of Manufacturing Plant In Mishawaka From Bayer HealthCare
Table 18: Siemens Medical Solutions Acquires Diagnostics Division Of Bayer Healthcare
Table 19: Bayer HealthCare Completes Acquisition Of iSense
Table 20: Bayer HealthCare Diabetes Care Acquires Metrika
Table 21: USD to Local Currency, Average Exchange Rate, 2011

1.2 List of Figures
Figure 1: Diabetes Care Devices (Glucose Monitoring), Global, Market Share (%), 2011
Figure 2: Bayer HealthCare AG, Diabetes Care Devices (Glucose Monitoring), by Region, Market Share (%), 2011
Figure 3: Bayer HealthCare AG, Diabetes Care Devices (Glucose Monitoring), by Country, Market Share (%), 2011
Figure 4: Bayer HealthCare AG, Deals Volume Summary, 2006 to YTD 2012

Watson Pharmaceuticals, Inc.
GlaxoSmithKline plc
Pfizer Inc.
Johnson & Johnson
Novartis Pharma AG
Merck & Co., Inc.
Becton, Dickinson and Company
Arkray, Inc.
LifeScan, Inc.
F. Hoffmann-La Roche Ltd.
Terumo Corporation
Abbott Laboratories
Nipro Corporation
Medtronic, Inc.
Apex Biotechnology Corp.
A. Menarini Diagnostics S.r.l.
B. Braun Melsungen AG
TaiDoc Technology Corporation
BIONIME Corporation

Note: Product cover images may vary from those shown

RELATED PRODUCTS